Literature DB >> 22956842

Taurine release by astrocytes modulates osmosensitive glycine receptor tone and excitability in the adult supraoptic nucleus.

Katrina Y Choe1, James E Olson, Charles W Bourque.   

Abstract

Cells can release the free amino acid taurine through volume-regulated anion channels (VRACs), and it has been hypothesized that taurine released from glial cells is capable of inhibiting action potential (AP) firing by activating neuronal glycine receptors (GlyRs) (Hussy et al., 1997). Although an inhibitory GlyR tone is widely observed in the brain, it remains unknown whether this specifically reflects gliotransmission because most neurons also express VRACs and other endogenous molecules can activate GlyRs. We found that VRACs are absent in neurons of the rat supraoptic nucleus (SON), suggesting that glial cells are the exclusive source of taurine in this nucleus. Application of strychnine to rat hypothalamic explants caused a depolarization of SON neurons associated with a decrease of chloride conductance and could excite these cells in the absence of fast synaptic transmission. This inhibitory GlyR tone was eliminated by pharmacological blockade of VRACs, by cellular taurine depletion, by metabolic inactivation of glia with fluorocitrate, and after retraction of astrocytic processes that intercalate neuronal somata and dendrites. Finally, GlyR tone varied inversely with extracellular fluid tonicity to mediate the osmotic control of AP firing by SON neurons. These findings establish taurine as a physiological gliotransmitter and show that gliotransmission is a spatially constrained process that can be modulated by the morphological rearrangement of astrocytes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22956842      PMCID: PMC6621246          DOI: 10.1523/JNEUROSCI.1380-12.2012

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  27 in total

Review 1.  Hypothalamic Signaling in Body Fluid Homeostasis and Hypertension.

Authors:  Brian J Kinsman; Haley N Nation; Sean D Stocker
Journal:  Curr Hypertens Rep       Date:  2017-06       Impact factor: 5.369

Review 2.  Role of astroglia in diet-induced central neuroplasticity.

Authors:  Courtney Clyburn; Kirsteen N Browning
Journal:  J Neurophysiol       Date:  2019-01-30       Impact factor: 2.714

3.  Modulation of spike clustering by NMDA receptors and neurotensin in rat supraoptic nucleus neurons.

Authors:  Ariane Gagnon; Michael Walsh; Tika Okuda; Katrina Y Choe; Cristian Zaelzer; Charles W Bourque
Journal:  J Physiol       Date:  2014-07-25       Impact factor: 5.182

4.  PAR1-activated astrocytes in the nucleus of the solitary tract stimulate adjacent neurons via NMDA receptors.

Authors:  Katie M Vance; Richard C Rogers; Gerlinda E Hermann
Journal:  J Neurosci       Date:  2015-01-14       Impact factor: 6.167

Review 5.  VRACs and other ion channels and transporters in the regulation of cell volume and beyond.

Authors:  Thomas J Jentsch
Journal:  Nat Rev Mol Cell Biol       Date:  2016-04-01       Impact factor: 94.444

Review 6.  Disentangling the Role of Astrocytes in Alcohol Use Disorder.

Authors:  Louise Adermark; M Scott Bowers
Journal:  Alcohol Clin Exp Res       Date:  2016-08-01       Impact factor: 3.455

Review 7.  The neural basis of homeostatic and anticipatory thirst.

Authors:  Claire Gizowski; Charles W Bourque
Journal:  Nat Rev Nephrol       Date:  2017-11-13       Impact factor: 28.314

Review 8.  The signaling role for chloride in the bidirectional communication between neurons and astrocytes.

Authors:  Corinne S Wilson; Alexander A Mongin
Journal:  Neurosci Lett       Date:  2018-01-09       Impact factor: 3.046

Review 9.  Physiology of Astroglia.

Authors:  Alexei Verkhratsky; Maiken Nedergaard
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

10.  Gq-DREADD Selectively Initiates Glial Glutamate Release and Inhibits Cue-induced Cocaine Seeking.

Authors:  Michael D Scofield; Heather A Boger; Rachel J Smith; Hao Li; Philip G Haydon; Peter W Kalivas
Journal:  Biol Psychiatry       Date:  2015-02-24       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.